SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001610618-19-000022
Filing Date
2019-04-26
Accepted
2019-04-26 16:15:08
Documents
4
Period of Report
2019-06-17
Effectiveness Date
2019-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A cdtxdef14a2019-04x26.htm DEF 14A 579622
2 cdtxlogoa02.jpg GRAPHIC 46741
3 proxycard2019001.jpg GRAPHIC 153608
4 proxycard2019002.jpg GRAPHIC 141167
  Complete submission text file 0001610618-19-000022.txt   1046049
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36912 | Film No.: 19771926
SIC: 2836 Biological Products, (No Diagnostic Substances)